Related Experiment Videos
Growth factor gene therapy for Alzheimer disease
Mark H Tuszynski1, Hoi Sang U, John Alksne
1Department of Neurosciences, Division of Neurosurgery, University of California at San Diego, La Jolla, California 92093, USA. mtuszynski@ucsd.edu
Neurosurgical Focus
|March 17, 2005
Summary
Gene therapy offers a promising approach to deliver nerve growth factors, potentially preventing neuronal death in Alzheimer disease (AD). This method aims to overcome challenges in delivering growth factors to the brain for effective treatment.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Progressive neurological disorders like Alzheimer disease (AD) involve neuronal degeneration and death.
- Nervous system growth factors show potential in animal models for preventing neuronal death and reversing age-related neuronal atrophy.
- Clinical application of growth factor therapy is hindered by challenges in delivering sufficient concentrations to the brain.
Purpose of the Study:
- To explore gene therapy as a method for delivering nerve growth factor (NGF) to the central nervous system.
- To assess the potential of NGF gene delivery for reducing neuronal cell loss in Alzheimer disease.
Main Methods:
- Review of the development and implementation of nerve growth factor gene delivery strategies.
- Focus on targeted and effective delivery of growth factors to the central nervous system.
Main Results:
- Gene therapy presents a viable strategy for targeted delivery of growth factors to the brain.
- Nerve growth factor gene delivery shows potential for therapeutic intervention in neurodegenerative conditions.
Conclusions:
- Nerve growth factor gene delivery is a promising therapeutic avenue for combating neuronal degeneration in Alzheimer disease.
- Overcoming delivery challenges through gene therapy could enable effective treatment for AD and similar disorders.